Douglas Lane & Associates LLC Grows Stock Holdings in Haleon plc (NYSE:HLN)

Douglas Lane & Associates LLC lifted its position in Haleon plc (NYSE:HLN) by 1.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,624,149 shares of the company’s stock after buying an additional 161,865 shares during the period. Haleon makes up about 1.2% of Douglas Lane & Associates LLC’s portfolio, making the stock its 23rd largest position. Douglas Lane & Associates LLC owned approximately 0.19% of Haleon worth $82,274,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. FMR LLC increased its holdings in shares of Haleon by 5.8% during the third quarter. FMR LLC now owns 104,918,269 shares of the company’s stock valued at $1,110,035,000 after acquiring an additional 5,768,117 shares in the last quarter. Clearbridge Investments LLC lifted its stake in shares of Haleon by 8.6% during the second quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company’s stock worth $344,888,000 after buying an additional 3,307,009 shares during the period. Wellington Management Group LLP grew its holdings in shares of Haleon by 49.9% during the third quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company’s stock valued at $96,833,000 after buying an additional 3,046,841 shares during the last quarter. Sculptor Capital LP increased its position in shares of Haleon by 67.8% in the 2nd quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock valued at $73,407,000 after acquiring an additional 3,592,000 shares during the period. Finally, Envestnet Asset Management Inc. raised its stake in Haleon by 2.7% in the 2nd quarter. Envestnet Asset Management Inc. now owns 7,572,548 shares of the company’s stock worth $62,549,000 after acquiring an additional 196,843 shares during the last quarter. Institutional investors own 6.67% of the company’s stock.

Haleon Trading Up 0.4 %

NYSE:HLN traded up $0.04 during trading hours on Wednesday, hitting $9.50. The company had a trading volume of 9,465,626 shares, compared to its average volume of 7,131,563. Haleon plc has a 1 year low of $7.89 and a 1 year high of $10.80. The company has a market cap of $43.00 billion, a P/E ratio of 27.94, a P/E/G ratio of 2.95 and a beta of 0.29. The company has a 50-day moving average of $9.62 and a 200 day moving average of $9.67. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday. Morgan Stanley raised their price target on shares of Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a research report on Friday, September 20th. Finally, UBS Group raised shares of Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $10.95.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.